Sandra Kirsch Heibel

Sandra Kirsch Heibel has a diverse work experience in the fields of science, regulatory affairs, and project management. Their most recent position is as the Chief Operating Officer at Audacity Therapeutics, PBC since February 2022. Prior to that, they worked at Haffner Associates, LLC as the Chief of Science and Regulatory Affairs, Senior Consultant, and Consultant. Sandra also served as an Expert Consultant and Chief Science Officer at BioPharma Global. Sandra's experience in project management includes roles as a Project Manager at BioPontis Alliance for Rare Diseases and Coté Orphan LLC. Sandra started their career as a Research Microbiologist at USDA-ARS and later worked as a Research Assistant at Children's National Medical Center. Currently, Sandra is preparing to join The 90 / 10 Institute as the Director of Programs in 2023.

Sandra Kirsch Heibel's education history includes a Doctor of Philosophy degree in Molecular and Cellular Biology from the University of Maryland, College Park and Children's National Medical Center. Prior to that, they obtained a Master of Science degree in Animal Science from the University of Maryland. Their undergraduate education was completed at Penn State University, where they earned a Bachelor of Science degree in Animal Bioscience.